Substance / Medication

Flubendazole

Overview

Active Ingredient
flubendazole
RxNorm CUI
25096

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Research Evidence

Published studies and systematic reviews

Sort:
Exploring flubendazole formulations for use in sheep. Pharmacokinetic evaluation of a cyclodextrin-based solution.
Ceballos Laura, Moreno Laura, Torrado Juan J et al. · BMC Vet Res · 2012
PMID: 22640491RCTFull text (PMC)
Flubendazole metabolism and biotransformation enzymes activities in healthy sheep and sheep with haemonchosis.
Bártíková H, Krízová V, Lamka J et al. · J Vet Pharmacol Ther · 2010
PMID: 20444026RCT
Evaluation of Three Amorphous Drug Delivery Technologies to Improve the Oral Absorption of Flubendazole.
Vialpando Monica, Smulders Stefanie, Bone Scott et al. · J Pharm Sci · 2016
PMID: 27113473ObservationalFull text (PMC)
Antiproliferative effect of benzimidazole anthelmintics albendazole, ricobendazole, and flubendazole in intestinal cancer cell lines.
Králová Věra, Hanušová Veronika, Staňková Petra et al. · Anticancer Drugs · 2013
PMID: 23884106Observational
Effects of the benzimidazole anthelmintic drug flubendazole on rat embryos in vitro.
Longo Monica, Zanoncelli Sara, Colombo Paolo Angelo et al. · Reprod Toxicol · 2013
PMID: 23287076Observational
Comparative performances of flubendazole and albendazole in cystic echinococcosis: ex vivo activity, plasma/cyst disposition, and efficacy in infected mice.
Ceballos Laura, Elissondo Celina, Sánchez Bruni Sergio et al. · Antimicrob Agents Chemother · 2011
PMID: 21930885ObservationalFull text (PMC)

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type
Substance / Medication
Fully Specified Name
Flubendazole (substance)
SNOMED CT
703367001
UMLS CUI
C0060477
RxNorm CUI
25096

Clinical Data

This intervention maps to 1 entities in the Ltrl knowledge graph.

1
Conditions
0
Biomarkers
0
Specialists
0
Symptoms

Data is sourced from SNOMED CT, UMLS, and the Ltrl clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.